CPTCF (Cytophage Technologies) Short-Term Capital Lease Obligation : $0.15 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Short-Term Capital Lease Obligation?

Cytophage Technologies's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.15 Mil.

Cytophage Technologies's quarterly Short-Term Capital Lease Obligation increased from Jun. 2024 ($0.22 Mil) to Sep. 2024 ($0.22 Mil) but then declined from Sep. 2024 ($0.22 Mil) to Dec. 2024 ($0.15 Mil).

Cytophage Technologies's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.08 Mil) to Dec. 2023 ($0.26 Mil) but then declined from Dec. 2023 ($0.26 Mil) to Dec. 2024 ($0.15 Mil).

Cytophage Technologies Short-Term Capital Lease Obligation Historical Data

The historical data trend for Cytophage Technologies's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Short-Term Capital Lease Obligation Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

0.12

0.08

0.26

0.15

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial						0.26	0.24	0.22	0.22	0.15

Cytophage Technologies Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Cytophage Technologies Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (GREY:CPTCF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

CYTO:Canada

Address

200A - 400 Fort Whyte Way, Oak Bluff, Oak Bluff, MB, CAN, R4G 0B1

Website

https://www.cytophage.com

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics.